NCT02261636View on ClinicalTrials.gov

Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 14, 2019

Study Completion Date

January 14, 2019

Conditions
Ulcerative Colitis
Interventions
DRUG

mesalazine

Trial Locations (1)

Unknown

Gelre Ziekenhuizen (there may be other sites in this country), Zutphen

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY